Subgroup analyses for all-cause mortality
Outcomes | Variable | Group | Number of cohorts | RRR and 95% CI | P value | I2 (%) | P value for heterogeneity | P value for meta-regression |
All-cause mortality | Publication year | Before 2010 | 7 | 1.51 (1.23 to 1.85) | <0.001 | 38.2 | 0.138 | – |
2010 or after | 0 | – | – | – | – | |||
Country | Western | 6 | 1.63 (1.41 to 1.88) | <0.001 | 8.2 | 0.364 | 0.039 | |
Eastern | 1 | 0.71 (0.33 to 1.55) | 0.394 | – | – | |||
Sample size | ≥10 000 | 3 | 1.66 (1.46 to 1.90) | <0.001 | 0.0 | 0.772 | 0.050 | |
<10 000 | 4 | 1.06 (0.59 to 1.90) | 0.844 | 43.7 | 0.149 | |||
Assessment of DM | Self-reported | 2 | 1.69 (1.46 to 1.95) | <0.001 | 0.0 | 0.669 | 0.123 | |
Measured | 4 | 1.06 (0.59 to 1.90) | 0.844 | 43.7 | 0.149 | |||
Both | 1 | 1.50 (1.03 to 2.19) | 0.035 | – | – | |||
Follow-up duration (years) | ≥10 | 7 | 1.51 (1.23 to 1.85) | <0.001 | 38.2 | 0.138 | – | |
<10 | 0 | – | – | – | – | |||
Adjusted other CVD risk factors | Yes | 4 | 1.50 (1.12 to 2.01) | 0.006 | 39.4 | 0.176 | 0.850 | |
No | 3 | 1.33 (0.75 to 2.36) | 0.321 | 57.6 | 0.095 | |||
Study quality | High | 2 | 1.69 (1.41 to 2.02) | <0.001 | 0.0 | 0.490 | 0.414 | |
Low | 5 | 1.25 (0.80 to 1.94) | 0.329 | 53.3 | 0.073 |
CVD, cardiovascular disease; DM, diabetes mellitus.